UGI Earnings

UGI reported its earnings on 2026-02-04, showcasing a revenue of 2.08B against an estimate of 2.13B, resulting in a -2.21% surprise. The EPS was 1.26, surpassing the expected 1.5 by -16% . The stock experienced a -6.34% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following UGI's earnings announcement on 2026-02-04, the stock price moved by -6.34% on the day of the release. Over the subsequent five days, it saw a % change. Historically, UGI's stock price tends to shift by an average of -2.50% in the 10 days leading up to earnings and +2.48% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate UGI’s annual revenue to reach 3.19B, while the EPS is projected at 2.16. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates No Change by 0% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between UGI's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2026 were No Change by 0%, while EPS estimates moved No Change by 0% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, UGI's stock price typically moves by -2.50% in the 10 days before its earnings and +2.48% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 2.16 and revenue of 3.19B.

The earnings call presents a mixed picture: strong EBIT growth in some segments and improved liquidity, but a decline in adjusted EPS and challenges in the Midstream & Marketing segment. The Q&A reveals some operational improvements and strategic focus but lacks clarity in certain responses. The financial performance and strategic plans seem balanced, leading to a neutral outlook. The market cap suggests moderate sensitivity to these factors, hence a neutral prediction (-2% to 2%) for the stock price over the next two weeks.